HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer McCormick Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

2/2014Notch-1 mediates endothelial cell activation and invasion in psoriasis.
6/2013Notch signalling pathways mediate synovial angiogenesis in response to vascular endothelial growth factor and angiopoietin 2.
4/2012Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer McCormick Research Topics

Disease

8Rheumatoid Arthritis
01/2016 - 01/2009
4Inflammation (Inflammations)
01/2016 - 04/2010
4Arthritis (Polyarthritis)
06/2013 - 01/2011
3Hypoxia (Hypoxemia)
06/2015 - 01/2011
2Giant Cell Arteritis (Horton Disease)
01/2019 - 09/2015
2Atherosclerosis
01/2019 - 09/2015
2Osteoarthritis
06/2013 - 01/2009
2Wounds and Injuries (Trauma)
06/2013 - 11/2011
2Psoriatic Arthritis
06/2013 - 04/2012
2Necrosis
02/2011 - 01/2009
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2014
1Brain Diseases (Brain Disorder)
01/2013
1Disease Progression
04/2012
1Heart Arrest (Cardiac Arrest)
03/2007

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
01/2019 - 06/2010
5Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2016 - 04/2010
4Proteins (Proteins, Gene)FDA Link
02/2014 - 04/2012
3Interleukin-6 (Interleukin 6)IBA
01/2019 - 01/2011
3Toll-Like Receptor 2IBA
01/2016 - 01/2011
3Small Interfering RNA (siRNA)IBA
06/2015 - 07/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 04/2012
3Interleukin-17 (Interleukin 17)IBA
11/2011 - 01/2009
2Biomarkers (Surrogate Marker)IBA
01/2019 - 04/2012
2Acute-Phase Proteins (Acute-Phase Protein)IBA
09/2015 - 06/2010
2LigandsIBA
02/2014 - 07/2012
2Messenger RNA (mRNA)IBA
02/2014 - 07/2012
2Factor VIII (Coagulation Factor VIII)IBA
02/2014 - 07/2012
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2013 - 07/2012
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
06/2013 - 07/2012
2EnzymesIBA
04/2012 - 11/2011
2ImmunosorbentsIBA
04/2012 - 11/2011
2Matrix Metalloproteinases (MMPs)IBA
04/2012 - 04/2010
2ChemokinesIBA
11/2011 - 06/2010
1WP1066IBA
06/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
06/2015
1Notch ReceptorsIBA
02/2014
1Jagged-1 ProteinIBA
02/2014
1EstersIBA
06/2013
1matrigelIBA
06/2013
1N-nitrosoiminodiacetic acidIBA
01/2013
1progelatinaseIBA
07/2012
1HRT1 protein HairyIBA
07/2012
1pro-matrix metalloproteinase 9IBA
07/2012
1delta proteinIBA
07/2012
1Tissue Inhibitor of MetalloproteinasesIBA
04/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
04/2012
1Collagen Type II (Type II Collagen)IBA
04/2012
1GelatinIBA
04/2012
1C-Reactive ProteinIBA
04/2012
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2011
1NSC 23766IBA
11/2011
1AntibodiesIBA
11/2011
1InterferonsIBA
02/2011
1Immunoglobulin G (IgG)IBA
02/2011
1Interleukin-8 (Interleukin 8)IBA
02/2011
1Adalimumab (Humira)FDA Link
02/2011
1ApoproteinsIBA
04/2010
1HDL LipoproteinsIBA
04/2010
1Oncostatin MIBA
01/2009
1neomyosuppressinIBA
03/2007

Therapy/Procedure

2Biological Therapy
04/2012 - 01/2009
1Therapeutics
04/2012